Prognostic value of lymphovascular invasion in patients with esophageal squamous cell carcinoma

被引:12
作者
Gu, Yi-Min [1 ]
Yang, Yu-Shang [1 ]
Hu, Wei-Peng [1 ]
Wang, Wen-Ping [1 ]
Yuan, Yong [1 ]
Chen, Long-Qi [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Thorac Surg, Chengdu 610041, Sichuan, Peoples R China
关键词
Esophageal squamous cell carcinoma (ESCC); esophagectomy; lymphovascular invasion (LVI); LYMPH-NODE METASTASIS; RESECTION MARGIN; TUMOR LENGTH; SURVIVAL; CANCER; ADENOCARCINOMA; NUMBER;
D O I
10.21037/atm.2019.05.23
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Whether lymphovascular invasion (LVI) in esophageal squamous cell carcinoma (ESCC) should be considered an independent prognostic factor for survival is controversial. The aim of this report was to investigate the prognostic value of LVI for patients with ESCC. Methods: Between October 2010 and July 2011, 152 ESCC patients were retrospectively reviewed. All of the patients underwent curative resection as their primary treatment. Clinicopathological features and overall survival (OS) rate were investigated. Kaplan-Meier curves were used to calculate the OS rate, and the prognostic factors were identified by Cox regression model. Results: Positive LVI was found in 49 (32.2%) patients. Patients with negative LVI had a significantly better 5-year OS rate than those with positive LVI (52.9% vs. 28.8%; P=0.000). The age, T stage, N stage, tumor differentiation, and LVI were demonstrated to be significant prognostic factors for OS through univariate analyses. LVI was confirmed as an independent prognostic factor for OS through multivariate survival analyses. Subgroup analyses revealed that LVI was associated with a decreased OS in node-negative patients, and no significant difference was observed in node-positive cases. Conclusions: Our study highlighted that LVI is an independent prognostic factor in patients with resectable ESCC. LVI may facilitate the stratification of patients with poor survival.
引用
收藏
页数:7
相关论文
共 32 条
[1]   Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial [J].
Alderson, Derek ;
Cunningham, David ;
Nankivell, Matthew ;
Blazeby, Jane M. ;
Griffin, S. Michael ;
Crellin, Adrian ;
Grabsch, Heike I. ;
Langer, Rupert ;
Pritchard, Susan ;
Okines, Alicia ;
Krysztopik, Richard ;
Coxon, Fareeda ;
Thompson, Joyce ;
Falk, Stephen ;
Robb, Clare ;
Stenning, Sally ;
Langley, Ruth E. .
LANCET ONCOLOGY, 2017, 18 (09) :1249-1260
[2]   Total number of resected lymph nodes predicts survival in esophageal cancer [J].
Altorki, Nasser K. ;
Zhou, Xi Kathy ;
Stiles, Brendon ;
Port, Jeffrey L. ;
Paul, Subroto ;
Lee, Paul C. ;
Mazumdar, Madhu .
ANNALS OF SURGERY, 2008, 248 (02) :221-226
[3]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[4]   Update on Neoadjuvant Regimens for Patients with Operable Oesophageal/Gastrooesophageal Junction Adenocarcinomas and Squamous Cell Carcinomas [J].
Cox, Samantha J. ;
O'Cathail, Sean M. ;
Coles, Bernadette ;
Crosby, Tom ;
Mukherjee, Somnath .
CURRENT ONCOLOGY REPORTS, 2017, 19 (01)
[5]   Prognostic factors for the survival of patients with esophageal carcinoma in the US - The importance of tumor length and lymph node status [J].
Eloubeidi, MA ;
Desmond, R ;
Arguedas, MR ;
Reed, CE ;
Wilcox, CM .
CANCER, 2002, 95 (07) :1434-1443
[6]  
Gen P, 2008, CANCER-AM CANCER SOC, V112, P1020, DOI [10.1002/cncr23265, 10.1002/cncr.23265]
[7]   Prognostic significance of tumor length in patients receiving esophagectomy for esophageal cancer [J].
Hollis, Alexander C. ;
Quinn, Lauren M. ;
Hodson, James ;
Evans, Emily ;
Plowright, James ;
Begum, Ruksana ;
Mitchell, Harriet ;
Hallissey, Mike T. ;
Whiting, John L. ;
Griffiths, Ewen A. .
JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (08) :1114-1122
[8]   Identification and Validation of Lymphovascular Invasion as a Prognostic and Staging Factor in Node-Negative Esophageal Squamous Cell Carcinoma [J].
Huang, Qingyuan ;
Luo, Kongjia ;
Chen, Chun ;
Wang, Geng ;
Jin, Jietian ;
Kong, Min ;
Li, Bifeng ;
Liu, Qianwen ;
Li, Jinhui ;
Rong, Tiehua ;
Chen, Haiquan ;
Zhang, Lanjun ;
Chen, Yuping ;
Zhu, Chengchu ;
Zheng, Bin ;
Wen, Jing ;
Zheng, Yuzhen ;
Tan, Zihui ;
Xie, Xiuying ;
Yang, Hong ;
Fu, Jianhua .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) :583-592
[9]   Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy [J].
Hulshoff, J. B. ;
Faiz, Z. ;
Karrenbeld, A. ;
Kats-Ugurlu, G. ;
Burgerhof, J. G. M. ;
Smit, J. K. ;
Plukker, J. Th. M. .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 :S1301-S1309
[10]   ESOPHAGEAL SQUAMOUS-CELL CARCINOMA - PATHOLOGY AND PROGNOSIS [J].
IDE, H ;
NAKAMURA, T ;
HAYASHI, K ;
ENDO, T ;
KOBAYASHI, A ;
EGUCHI, R ;
HANYU, F .
WORLD JOURNAL OF SURGERY, 1994, 18 (03) :321-330